MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $3,837,000 | -35.2% | 275,024 | -14.1% | 0.64% | -28.5% |
| Q3 2017 | $5,921,000 | -42.1% | 320,055 | -47.1% | 0.90% | -39.4% |
| Q2 2017 | $10,234,000 | +1.3% | 605,545 | -20.0% | 1.49% | -7.4% |
| Q1 2017 | $10,103,000 | -21.5% | 756,765 | -11.5% | 1.61% | -33.6% |
| Q4 2016 | $12,872,000 | +20.9% | 855,265 | -10.8% | 2.42% | +30.0% |
| Q3 2016 | $10,644,000 | +7.7% | 958,879 | +4.8% | 1.86% | -0.7% |
| Q2 2016 | $9,882,000 | +37.1% | 914,979 | +17.3% | 1.88% | +26.4% |
| Q1 2016 | $7,210,000 | +14.4% | 780,313 | +83.8% | 1.48% | -8.3% |
| Q4 2015 | $6,300,000 | +9.4% | 424,536 | +21.0% | 1.62% | +3.8% |
| Q3 2015 | $5,759,000 | +79.8% | 350,920 | +149.9% | 1.56% | +90.6% |
| Q2 2015 | $3,203,000 | +20.3% | 140,440 | -19.8% | 0.82% | +16.2% |
| Q1 2015 | $2,662,000 | +10.0% | 175,100 | +28.0% | 0.70% | +7.8% |
| Q4 2013 | $2,419,000 | -10.0% | 136,800 | -26.8% | 0.65% | -5.4% |
| Q3 2013 | $2,688,000 | +8.2% | 186,800 | +13.2% | 0.69% | -4.8% |
| Q2 2013 | $2,485,000 | – | 165,000 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
| Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
| Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
| Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
| Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
| Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
| Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
| Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
| Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
| Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |